Repeat Dose Toxicity. 1 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 [*][Exclusion of confidential technical information] 3 The following report is described in the report 4.2.3.2(5): [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information]
Appears in 1 contract
Repeat Dose Toxicity. 1 [*]] [Exclusion of confidential technical information] 3 [*]] [Exclusion of confidential technical information] 3 [*]] [Exclusion of confidential technical information] 3 [*]] [Exclusion of confidential technical information] 3 [*]] [Exclusion of confidential technical information] 3 The following report is described in the report 4.2.3.2(5): [*]] [Exclusion of confidential technical information] 3 [*] [Exclusion of confidential technical information] 4 [*]] [Exclusion of confidential technical information] 4 [*]] [Exclusion of confidential technical information] 4 [*]] [Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information] 4 [*][Exclusion of confidential technical information]
Appears in 1 contract
Sources: Technology Transfer and Technical Assistance Agreement (Aeterna Zentaris Inc.)